Skip to main content
SpringerLink
Log in

Integrin-Linked Kinase (ILK) in Combination Molecular Targeting

  • Chapter
Molecular Targeting and Signal Transduction

Part of the book series: Cancer Treatment and Research ((CTAR,volume 119))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hannigan, GE., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, MG., Radeva, G., Filmus, J., Bell, JC., Dedhar, S. (1996). Regulation of cell adhesion and anchoragedependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91–96.

    Article  CAS  PubMed  Google Scholar 

  2. Giancotti, FG & Ruoslahti, E. (1999). Integrin signaling. Science 285: 1028–1032.

    Article  CAS  PubMed  Google Scholar 

  3. Tu, Y., Huang, Y., Zhang, Z., Hua, Y., Wu, C. (2001). A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153: 585–598.

    Article  CAS  PubMed  Google Scholar 

  4. Yamaji, S., Suzuki, A., Sugiyama, Y., Koide, Y., Yoshida, M., Kanamori, H., Mohri, H., Ohno, S., Ishigatsubo, Y. (2001). A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol 153: 1251–1264.

    Article  CAS  PubMed  Google Scholar 

  5. Nikolopoulos, SN., Turner, CE. (2001). Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J Biol Chem 276: 23499–23505.

    Article  CAS  PubMed  Google Scholar 

  6. Guo, L., Wu, C. (2002). Regulation of fibronectin matrix deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J 16: 1298–1300.

    CAS  PubMed  Google Scholar 

  7. Lynch DK., Ellis, CA., Edwards, PA, Hiles, ID (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18: 8024–8032.

    CAS  PubMed  Google Scholar 

  8. Graff, JR., Deddens, JA., Konicek, BW, Colligan, BM., Hurst, BM., Carter, HW, Carter, JH. (2001). Integrin-linked kinase expression increases with prostate tumor grad. Clin Can Res 7: 1987–1991.

    CAS  Google Scholar 

  9. Stambolic, V., Suzuki, A., de la Pompa, JL., Brothers, GM., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, JM., Siderovski, DP., Mak, TW. (1998). Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29–39.

    Article  CAS  PubMed  Google Scholar 

  10. D’Amico, M., Hulit, J., Amanatullah, DF., Zafonte, BT., Albanese, C., K-I., Moon, RT., Davis, R, Lisanti, MP., Shtutman, M., Zhurinsky, J., Ben-Ze’ev, A., Troussard, AA., Dedhar, S., Pestell, RG. (2000). The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649–32657.

    Google Scholar 

  11. Radeva, G., Petrocelli, T., Behrend, E., Leung-Hagesteijn, C., Filmus, J., Slingerland, J., Dedhar, S. (1997). Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272: 13937–13944.

    Article  CAS  PubMed  Google Scholar 

  12. Nicholson, KM., Anderson, NG. (2002). Cell Signal. 14: 381–395.

    Article  CAS  PubMed  Google Scholar 

  13. Persad, S., Attwell, S., Gray, V., Mawji, N., Deng, JT., Leung, D., Yan, J., Sanghera, J., Walsh, MP., Dedhar, S. (2001). Regulation of Protein Kinase B/Akt-Serine 473 Phosphorylation by Integrin-linked Kinase. J Biol Chem 276(29): 27462–27469.

    Article  CAS  PubMed  Google Scholar 

  14. Kiss, E., Muranyi, A., Csortos, C., Gergely, P., Ito, M., Hartshorne, DJ, Erdodi, F. (2002). Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton. Biochem J 365: 79–87.

    Article  CAS  PubMed  Google Scholar 

  15. Persad, S., Attwell, S., Gray, V., Delcommenne, M., Troussard, A., Sanghera, J., Dedhar, S. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 3207–1322.

    Article  CAS  PubMed  Google Scholar 

  16. Wu, C., Keightley, SY., Leung-Hagesteijn, C., Radeva, G., Coppolino, M., Goicoechea, S., McDonald, JA., Dedhar, S. (1998). Integrin-linked protein kinase regulates fibronectrin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273: 528–536.

    CAS  PubMed  Google Scholar 

  17. Attwell, S., Roskelley, C., Dedhar, S. (2000). The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19: 3811–3815.

    Article  CAS  PubMed  Google Scholar 

  18. Downward, J (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10: 262–267.

    Article  CAS  PubMed  Google Scholar 

  19. Cardone, MH., Roy, N., Stennicke, HR et al. (1998). Regulation of cel death protease caspase-9 by phosphorylation. Science 282: 1318–1321.

    Article  CAS  PubMed  Google Scholar 

  20. Troussard, AA., Tan, C., Yoganathan, TN., Dedhar, S (1999). Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase-and glycogen synthase kinase 3-dependent manner. Mol Cell Biol 19: 7420–7427.

    CAS  PubMed  Google Scholar 

  21. Tan, C., Costello, P., Sanghera, J., Dominguez, D., Baulida, J., de Herreros, AG., Dedhar, S. (2001) Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/-human colon carcinoma cells. Oncogene 20: 133–140.

    Article  CAS  PubMed  Google Scholar 

  22. White, DE., Cardiff, RD., Dedhar, S., Muller, WJ. (2001). Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland Hyperplasias and tumors in transgenic mice. Oncogene 20: 7064–7072.

    CAS  PubMed  Google Scholar 

  23. Chung, DH., Lee, JI., Kook, MC., Kim, JR., Kim, SH., Choi, EY., Park, SH., Song, HG. (1998). ILK (beta 1 integrin-linked protein kinase): A novel immunohistochemical marker for Ewing’s sarcoma and primitive neuroectodermal tumor. Virchows Arch 433: 113–117.

    Article  CAS  PubMed  Google Scholar 

  24. Ahmed, N., Riley, C., Olica, K., Stutt, E., Rice, GE., Quinn, MA. (2003). Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. The Journal of Pathology (In press)

    Google Scholar 

  25. Berx, G., Van Roy, F. (2001). The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant proression. Breast Cancer Res 3: 289–293.

    Article  CAS  PubMed  Google Scholar 

  26. Marotta, A., Tan, C., Gray, V., Malik, S., Gallinger, S., Sanghera, J., Dupuis, B., Owen, D., Dedhar, S., & Salh, B. (2001). Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene 20: 6250–6257.

    Article  CAS  PubMed  Google Scholar 

  27. Wang, SC., Makino, K., Xia, W., Kim, JS., Im, SA., Peng, H., Mok, SC., Singletary, SE., Jung, MC. (2001). DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene 20: 6960–6964.

    CAS  PubMed  Google Scholar 

  28. Takada, T., Noguchi, T., Inagaki, K., Hosooka, T., Fukunaga, K., Yamao, T., Ogawa, W., Matozaki, T., Kasuga, M. (2002). Induction of apoptosis by stomach cancer-associated protein-tyrosine phosphatase-1 (SAP-1). J Biol Chem 277: 34359–34366.

    Article  CAS  PubMed  Google Scholar 

  29. Leung-Hagesteijn, C., Mahendra, A., Naruszewicz, I., Hannigan, GE. (2001). Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J 20(9): 2160–2170.

    Article  CAS  PubMed  Google Scholar 

  30. Dedhar, S. (2000). Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 12: 250–256.

    Article  CAS  PubMed  Google Scholar 

  31. Marotta, A., Parhar, K., Owen, D., Dedhar, S., Salh, B. (2003). Characterisation of integrin-linked kinase siganlling in sporadic human colon cancer. BJC 88: 1755–1762.

    CAS  PubMed  Google Scholar 

  32. Delecommenne, M., Tan C., Gray, V., Rue, L., Woodgett, J., Dedhar, S. (1998). Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211–11216.

    Google Scholar 

  33. Chou, T.-C. and Talalay, P. (1984). Generalized equations for the analysis of inhibitors of Michaelis-Menten and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Europ J Biochem 115: 207–217.

    Google Scholar 

  34. Greco, WR., Bravo, G., Parsons, JC. (1995). The Search for Synergy: A Critical Review from a Response Surface Perspective. The Amer Soc Pharm Exp Ther 47(2): 332–3382.

    Google Scholar 

  35. Chou, T-C. (1974). Relationships between inhibition constants and fractional inhibitions in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types of mechanisms of inhibition. Mol Pharmacol 10: 235–247.

    CAS  PubMed  Google Scholar 

  36. Chou, T.C. (1976). Derivation and properties of Michaelis-Menten type and Hill type equeations for reference ligands. J Theoret Biol 65: 345–356.

    Google Scholar 

  37. Chou, T-C., and Talalay, P. (1983). Analysis of combined drug effects: A new look at a very old problem. Trends Pharmacol Sci 4: 450–454.

    Article  CAS  Google Scholar 

  38. Gorre, ME., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, N., Sawyers, CL (2001). Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification. Science 293: 876–880.

    Article  CAS  PubMed  Google Scholar 

  39. Barthe, C., Cony-Makhoul, P., Melo, JV., Reiffers Francois-Xavier Mahon, J., Hochhaus, A., Kreil, S., Corbin, A., Rosee, PL., Lahaye, T., Berger, U., Cross, NCP., Linkesch, W., Druker, BJ., Hehlmann, R., Passerini, CG., Corneo, G., D’Incalci, M., Gorre, M., Shah, N., Ellwood, K., Nicoll, J., Sawyers, CL. (2001). Roots of Clinical Resistance to STI-571 Cancer Therapy. Science 21: 2163.

    Google Scholar 

  40. Chou, T-C., Rideout, D., Chou, J., Bertino, JR. (1991). Chemotherapeutiv Synergism, Potentiation and Antagonism. Encyclopedia of Human Biology 2: 371–379.

    Google Scholar 

  41. Lopez-Ilasaca, M., Crespo, P., Pellici, PG., Gutkind, JS., Wetzker, R. (1997). Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ. Science 275: 394–397.

    Article  CAS  PubMed  Google Scholar 

  42. Nelson, JM., Fry, D. (2001). Akt, MAPK (Erk1/2), and p38 Act in Concert to Promote Apoptosis Response to ErbB Receptor Family Inhibition. JBC 276(18): 14842–14847.

    CAS  Google Scholar 

  43. Tan, C., Mui, A., Dedhar, S (2002). Integrin linked kinase regulates Inducible Nitric Oxide Synthase and Cyclooxygenase-2 (COX-2) Expression in a NF-kappa B-Dependent Manner JBC 277(5): 3109–16.

    CAS  Google Scholar 

  44. Yoganathan, N., Yee, A., Zhang, Z., Leung, D., Yan, J., Fazli, L., Kojic, DL., Costello, PC., Jabali, M., Dedhar, S., Sanghera, J (2002). Integrin-linked kinase, a promising cancer therapeutic target biochemical and biological properties. Pharm & Therapeut 93: 233–242.

    CAS  Google Scholar 

  45. Workman, P. (2000). Curr Opin Oncol Endocrin Metab Invest Drugs 2: 21–25.

    CAS  Google Scholar 

  46. Sausville, EA. (2000). Anti-Cancer Drug Design 15: 1–2.

    CAS  PubMed  Google Scholar 

  47. Hudes, G. (1999). J Clin Oncol 17: 1093–1094.

    CAS  PubMed  Google Scholar 

  48. Eisenhauer, EA. (1998). Annals Oncol 9: 1047–1052.

    CAS  Google Scholar 

  49. Morin, MJ. (2000). From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents. Oncogene 19: 6574–6583.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advanced Therapeutics, BC Cancer Agency and Research Centre, Department of Pathology & Laboratory Medicine, The University of British Columbia, Britich Columbia, Canada

    Lincoln A Edwards

  2. Advanced Therapeutics, BC Cancer Agency and Research Centre, Celator Technologies, Department of Pathology & Laboratory Medicine, The University of British Columbia, Britich Columbia, Canada

    Jennifer A Shabbits & Marcel Bally

  3. BC Cancer Agency; Cancer Biology Program, Department of Biochemistry and Molecular Biology, The University of British Columbia, Jack Bell Research Centre, British Comlumbia, Canada

    Shoukat Dedhar

Authors
  1. Lincoln A Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer A Shabbits
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcel Bally
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shoukat Dedhar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA

    Rakesh Kumar Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Edwards, L.A., Shabbits, J.A., Bally, M., Dedhar, S. (2004). Integrin-Linked Kinase (ILK) in Combination Molecular Targeting. In: Kumar, R. (eds) Molecular Targeting and Signal Transduction. Cancer Treatment and Research, vol 119. Springer, Boston, MA. https://doi.org/10.1007/1-4020-7847-1_4

Download citation

  • DOI: https://doi.org/10.1007/1-4020-7847-1_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7822-4

  • Online ISBN: 978-1-4020-7847-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation